Disclosure under Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 - Continual Disclosure consequent to Preferential Allotment of Equity Shares on a Share Swap Basis

iSERA LIFESCIENCES LIMITED (Formerly known as Covidh Technologies Limited) CIN: L72200PN1993PLC252720 Date: October 08, 2026 The Corporate Relationship Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, 25th Floor, Mumbai – 400 001 Subject: Disclosure under Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 — Continual Disclosure consequent to Preferential Allotment of Equity Shares on a Share Swap Basis Dear Sir / Madam, We wish to inform you that pursuant to the preferential allotment of equity shares of iSERA Lifesciences Limited (formerly known as Covidh Technologies Limited) on a Share Swap basis, the following allottees have acquired equity shares of the Company. The requisite disclosures under Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 in the prescribed Form C are enclosed herewith. The details of acquisition are as under: Sr. No. Name of Allottee No. of Equity Shares Acquired % of Paid-up Share Capital Nature of Transaction 1 Shubhangi Dhanraj Garad 27,55,000 4.95% Preferential Allotment — Share Swap 2 Sumeet Dhanraj Garad 11,92,000 4.06% Preferential Allotment — Share Swap 3 Pratap Dadasaheb Deshmukh 7,85,500 -1.11% Preferential Allotment — Share Swap 4 Ritu Dhanraj Garad 7,46,000 2.25% Preferential Allotment — Share Swap 5 Archana Kakasaheb Lonkar 4,95,000 -3.46% Preferential Allotment — Share Swap Office No. A1-1202, 12th Floor, Boulevard Tower, Phase-2, CTS No. 11, Sadhu Vaswani Chowk, Camp, Pune – 411001 Tel: +91 83290 12053 • Email: cscovidh@gmail.com • Website: www.covidhtechnologies.com iSERA LIFESCIENCES LIMITED (Formerly known as Covidh Technologies Limited) CIN: L72200PN1993PLC252720 6 Nandkumar Subhash Kadam 4,56,500 -6.87% Preferential Allotment — Share Swap 7 Dhairyasheel Vasantrao Yadav 4,50,500 -6.89% Preferential Allotment — Share Swap 8 Venkatesh Madhav Bhat 1,50,000 0.61% Preferential Allotment — Share Swap 9 Pravin Vaman Suryarao 1,00,000 0.41% Preferential Allotment — Share Swap 10 Madan Manohar Ballal 1,00,000 0.41% Preferential Allotment — Share Swap 11 Darshana Vikas Chavan 1,00,000 0.41% Preferential Allotment — Share Swap 12 Aadhar Kumar 1,00,000 0.41% Preferential Allotment — Share Swap 13 Ishita Rajesh Kumar 1,00,000 0.41% Preferential Allotment — Share Swap 14 Ujjwala Anil Mane 1,00,000 0.41% Preferential Allotment — Share Swap 15 Jyoti Manesh Waghirkar 1,00,000 0.41% Preferential Allotment — Share Swap 16 Archana Sitaram Kale 1,00,000 0.41% Preferential Allotment — Share Swap 17 Babasaheb Mahadeo Bhosale 80,000 0.33% Preferential Allotment — Share Swap 18 Sanjay Ramchandra Tarlekar 75,000 0.30% Preferential Allotment — Share Swap Office No. A1-1202, 12th Floor, Boulevard Tower, Phase-2, CTS No. 11, Sadhu Vaswani Chowk, Camp, Pune – 411001 Tel: +91 83290 12053 • Email: cscovidh@gmail.com • Website: www.covidhtechnologies.com iSERA LIFESCIENCES LIMITED (Formerly known as Covidh Technologies Limited) CIN: L72200PN1993PLC252720 19 Anita Sunil Nair 75,000 0.30% Preferential Allotment — Share Swap 20 Kamlakar Nivrutti Dandwate 70,000 0.28% Preferential Allotment — Share Swap 21 Sanjiv Dattatray Jadhav 50,000 0.20% Preferential Allotment — Share Swap 22 Shital Tushar Pawar 50,000 0.20% Preferential Allotment — Share Swap 23 Santosh Madhavrav Naik 50,000 0.20% Preferential Allotment — Share Swap 24 Yogesh Indrajit Somwanshi 50,000 0.20% Preferential Allotment — Share Swap 25 Lata Sanjiv Jadhav 50,000 0.20% Preferential Allotment — Share Swap 26 Sunita Santosh Patil 30,000 0.12% Preferential Allotment — Share Swap 27 Suman Ravindra Kunjir 30,000 0.12% Preferential Allotment — Share Swap 28 Sadhana Digambar Joshi 25,000 0.10% Preferential Allotment — Share Swap 29 Dilip Ganesh Kulkarni 25,000 0.10% Preferential Allotment — Share Swap 30 Anant Kamlakar Dandawate 25,000 0.10% Preferential Allotment — Share Swap 31 Mangina S. Rao 41,600 0.09% Preferential Allotment — Share Swap Office No. A1-1202, 12th Floor, Boulevard Tower, Phase-2, CTS No. 11, Sadhu Vaswani Chowk, Camp, Pune – 411001 Tel: +91 83290 12053 • Email: cscovidh@gmail.com • Website: www.covidhtechnologies.com iSERA LIFESCIENCES LIMITED (Formerly known as Covidh Technologies Limited) CIN: L72200PN1993PLC252720 The individual Form C disclosures of each of the above allottees are enclosed herewith as separate annexures. Kindly take the aforesaid on your records. Thanking You, Yours Faithfully, For and on behalf of iSERA Lifesciences Limited (Formerly known as Covidh Technologies Limited) (DEEPAKSHI) Company Secretary & Compliance Officer Membership No.: A76335 Office No. A1-1202, 12th Floor, Boulevard Tower, Phase-2, CTS No. 11, Sadhu Vaswani Chowk, Camp, Pune – 411001 Tel: +91 83290 12053 • Email: cscovidh@gmail.com • Website: www.covidhtechnologies.com On the Letter Head of the Entity FORM C SEBI (Prohibition of Insider Trading) Regulations, 2015 [Regulation 7 (2) read with Regulation 6(2) – Continual Disclosure] Name of the company: iSERA Lifesciences Limited ISIN of the company: INE899M01020 Details of change in holding of Securities of Promoter, Member of the Promoter Group Group, Designated Person or Director of a listed company and immediate relatives of such persons and other such persons as mentioned in Regulation 6(2). Name, Catego Securities held Securities acquired/Disposed Securities held Date of Date of Mode of Exchange PAN, ry of prior to post acquisition/ allotment intimation acquisition on which CIN/DIN, Person acquisition/ disposal advice/ to /disposal the trade & address (Promo disposal acquisition company (on market/ was with contact ter/m public/ executed nos. ember of shares/ rights/ of the disposal of preferential promot shares, offer/ er specify off market/ group/ Type of No. Type of No. Value Transa Type of No. and From To Inter-se desig securiti and securities c tion securitie % of transfer, nated es (For % of (For eg. Type s (For shareh ESOPs, person/ eg. share – (Purch eg. olding etc.) Directo – Shares holdin Shares, a – r Warrants, g Warrants, se/sale Shares, s/imme Convert Convertib Pledge Warrant diate ible le / s, relative Debentu Debentur Revoca Convert to/othe res, es, t ion / i ble rs etc.) Rights Rights Invocat Debentu entitlem entitleme i on/ r es, ents nt, etc.) Others- Rights etc.) please entitlem specify e nt, ) etc.) Babasaheb Promoter Equity Equity 80,000 38,56, Acquisitio Equity 80,0000 October October October Acquisition – N.A. Mahadeo Group Shares (0.00%) Shares 000 n– Shares (0.33%) 01, 2026 01, 2026 06, 2026 Preferential Bhosale, PAN Preferenti Allotment No- al (Share Swap) Allotment On the Letter Head of the Entity (Share Swap) AIMPB1046R Address- 1102, Hill view Residency Kharghar, Navi Mumbai Contact No- 9324298655 Note: (i) “Securities” shall have the meaning as defined under regulation 2(1)(i) of SEBI (Prohibition of Insider Trading) Regulations, 2015. (ii) Value of transaction excludes taxes/brokerage/any other charges Details of trading in derivatives on the securities of the company by Promoter, member of the promoter group, designated person or Director of a listed company and immediate relatives of such persons and other such persons as mentioned in Regulation 6(2). Trading in derivatives (Specify type of contract, Futures or Options etc.) Exchange on which the trade was executed Type of Contract Buy Sell contract specifications Notional Number of Notional Value Number of units Value units (contracts * lot (contracts * lot size) size) 16 17 18 19 20 21 22 Note: In case of Options, notional value shall be calculated based on Premium plus strike price of options. Name & Signature: Babasaheb Mahadeo Bhosale Designation: Promoter Group Date: October 06, 2026 Place: Pune On the Letter Head of the Entity FORM C SEBI (Prohibition of Insider Trading) Regulations, 2015 [Regulation 7 (2) read with Regulation 6(2) – Continual Disclosure] Name of the company: iSERA Lifesciences Limited I [Showing first 8,000 characters — download PDF for full document]